This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Entire content available on: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Therapeutics-Nirmatrelvir-ritonavir-Poster-B-2023.1
Language
EnglishTypology
Informative materials/FAQsTopic
Clinical Management Covid-19Target
Hospital/LTCF Primary careCountries
USA Canada South America Central America Caribbean Middle East South pacific China India Indochina Singapore Europe & UK Oceania Africa